52min or 80min original German/English/Hindi version with German or English subtitles available
Synopsis
Did you know that 20% of your genes are patented and owned by private corporations? In a creative investigation director Hannah Leonie Prinzler uncovers who profits from patents, and who bears the social consequences. Along her journey she meets British inventor James Dyson and American business gurus in the Silicon Valley. She learns the shocking story of our body’s genes that we don’t own and finds out about the war strategies that patent attorneys apply. She travels to Geneva, the world’s headquarter of patents, and to India, the largest manufacturer of generic, meaning patent free, medicines. She shows what India has come up with to protect its genetic resources and meets Anil Gupta, the ‘Gandhi of Innovation‘. At the end of her trip she has a look at the world’s first open-source car.
In order for our website to function optimally, we use cookies for some of our applications. This includes i.a. the embedded social media, but also a tracking tool that provides us with information about the ergonomics of our website and user behavior. If you click on "Accept all cookies", you agree to the use of technically necessary cookies and those to optimize our website. See "Cookie Settings" for more information.
Control settings
Please select your preferences. You can change these at any time.
In order for our website to function optimally, we use cookies for some of our applications. These cannot be deactivated, otherwise you will not be able to use all applications.
In order to make our website as user-friendly as possible, we have i.a. social media embedded on our website. This allows you to share content with your loved ones on the appropriate network with just a few clicks. We also use anonymous tracking technology, which gives us information about e.g. the user behavior, but also the effectiveness and ergonomics of our website. For this purpose, we also use services that may be based outside the European Union (especially in the USA), where the level of data protection may be lower than in Germany.